Okay, let's tackle this question. The patient is a 41-year-old male with a 5-year history of bloody diarrhea. He's been on sulfasalazine but still has exacerbations and needs steroids. The question is about the next line of treatment.

First, I need to recall the management of inflammatory bowel disease, specifically ulcerative colitis. Sulfasalazine is a first-line treatment for mild to moderate cases. If the patient isn't responding adequately, the next step would be to consider other options. Since he's had multiple flares despite sulfasalazine, maybe he's not responding well to 5-ASA agents.

The options probably include other 5-ASA agents like mesalamine, immunomodulators like azathioprine or 6-mercaptopurine, biologics like infliximab or adalimumab, or maybe even surgery. The correct answer here is likely an immunomodulator or a biologic. Since he's already on a 5-ASA and it's not working, moving to an immunomodulator would be the next step. Biologics are usually considered if immunomodulators fail or if there's a need for quicker response. However, the question might be pointing towards azathioprine as a maintenance therapy to reduce steroid dependence.

Wait, the patient is using steroids for flares. Steroids are not for long-term use. So the next step after 5-ASA failure is to add an immunomodulator to maintain remission. So the answer is likely an immunomodulator like azathioprine. The options might have that as option C or D. Let me check the structure again. The correct answer is probably option C: Azathioprine. Then the explanation would be that after 5-ASA and steroids, immunomodulators are next. The other options like other 5-ASA agents or biologics might be considered, but in the stepwise approach, azathioprine is the next line after 5-ASA and before biologics. Also, biologics are more for moderate to severe cases or when other treatments fail. Since he's already on sulfasalazine and steroids, the next step would be immunomodulator. So the correct answer is Azathioprine.

**Core Concept**
This question tests the stepwise management of ulcerative colitis (UC) in a patient with partial response to first-line therapy. The primary goal is maintaining remission and reducing steroid dependence, which requires escalation to immunomodulators or biologics after 5-aminosalicylic acid (5-ASA) failure.

**Why the Correct Answer is Right**
Sulfasalazine is a 5-ASA agent used for mild to moderate UC. In patients with inadequate response or frequent flares, the next step is introducing immunomodulators like azathioprine or 6-mercaptopurine. These drugs suppress T-cell activity, reducing inflammation, and allow steroid tapering. They are preferred over biologics for long-term maintenance due to lower cost and fewer infusion reactions. Steroid dependence is a key indicator for initiating immunomodulators to prevent complications like osteoporosis or adrenal suppression.

**Why Each Wrong Option is Incorrect**
**Option A:** _Mesalamine (another 5-ASA agent)_

✓ Correct Answer: B. Azathioprine